Skip to main content
. 2019 Nov 25;56(1):123–138. doi: 10.3892/ijo.2019.4921

Figure 4.

Figure 4

Detection of TfR and Ki-67 expression by immunohistochemistry. (A) TfR in tubulopapillary breast adenocarcinoma. (B) TfR in soft tissue sarcoma. (C) TfR in squamous cell carcinoma. (D) TfR in the negative control. (E) Ki-67 in tubulopapillary breast adenocarcinoma. (F) Ki-67 in soft tissue sarcoma. (G) Ki-67 in squamous cell carcinoma. (H) Ki-67 in neuroendocrine carcinoma. Magnification, x40. TfR, transferrin receptor.